Rodrigo Landeros, PA
Surgical · Edmonds, WANPI 1902253172
Payments from drug & device makers
What this record shows
Axonics, Inc. accounts for 74.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $2,061 and has fallen 91.5% since, to $176 in 2025. Among surgical clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $77.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$2K
- Teleflex LLC$256
- Sumitomo Pharma America, Inc.$70
- AbbVie$64
- Urogen Pharma, Inc.$35
- Antares Pharma, Inc.$35
- plus $125 from 5 others
What the payments were for
- Travel & lodging$1,29756%
- Food & beverage$1,01544%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 13 | $1,727 |
| Teleflex LLC | 6 | $256 |
| Sumitomo Pharma America, Inc. | 2 | $70 |
| AbbVie | 2 | $64 |
| Urogen Pharma, Inc. | 1 | $35 |
| Antares Pharma, Inc. | 1 | $35 |
| Myriad Genetic Laboratories, Inc. | 1 | $32 |
| Progenics Pharmaceuticals, Inc. | 1 | $29 |
| Boston Scientific | 1 | $27 |
| Novartis | 1 | $20 |
| Tolmar, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,312 in reported general payments places this provider in the 90th percentile of 404 surgical providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 93 | $68,152 |
| Tamsulosin Hcl | 485 | $7,045 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 174 | $3,471 |
| Testosterone | 23 | $2,822 |
| Potassium Citrate ErPotassium Citrate | 31 | $2,819 |
| Solifenacin Succinate | 45 | $2,294 |
| Finasteride | 185 | $2,226 |
| Tolterodine Tartrate ErTolterodine Tartrate | 31 | $2,021 |
| Oxybutynin Chloride ErOxybutynin Chloride | 93 | $1,851 |
| Estradiol | 16 | $1,564 |
| Tolterodine Tartrate | 14 | $971 |
| Testosterone Cypionate | 22 | $957 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 30 | $734 |
| Dutasteride | 21 | $548 |
| Trospium Chloride | 13 | $451 |
Paid to pharmacies, not to this prescriber.
Other surgical in Edmonds
- Matthew RothstromEdmonds$8K
- Nicholas DichiaraEdmonds$3K
- Gretchen ThornerYakima$612K
- Jana FlenerRenton$93K
- Jeffrey StepanianKirkland$52K
- Jin Lo TomblinSpokane$21K
- Philip HujdicRenton$17K
- Mark MashitaEverett$16K
- Lee Or RutenbergSeattle$13K
- Wesley SumrallBremerton$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.